They were supposed (targeted) to submit for FDA approval in Q4 CY2023. It's now targeted for Q1/Q2 CY2024. 3-6 months late is a long time in Investorland. I'd hope the news revolves around something out of the UK. If no news, we'd be tempted to dump a chunk and replace them ~20% cheaper next month
They were supposed (targeted) to submit for FDA approval in Q4...
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $50.71M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $39.10K | 1.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 957373 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 175237 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 3.1¢ | 3.1¢ | 2.9¢ | 76478 | ||
| Last updated 11.56am 26/04/2024 ? | |||||
| PCK (ASX) Chart |